发明名称 |
Vaccine composition |
摘要 |
A multi-valent vaccine composition is described comprising a conjugate of the capsular polysaccharide of H. influenzae b not adsorbed onto an aluminum adjuvant salt, and two or more further bacterial polysaccharides. A multi-valent vaccine composition is also described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, Hepatitis B surface antigen, a conjugate of the capsular polysaccharide of H. influenzae b, and a conjugate of a capsular polysaccharide of N. meningitidis type A or C (or both). Furthermore, a multi-valent vaccine composition is described comprising a whole-cell pertussis component, tetanus toxoid, diphtheria toxoid, and a low dose of a conjugate of the capsular polysaccharide of H. influenzae b. |
申请公布号 |
US9233151(B2) |
申请公布日期 |
2016.01.12 |
申请号 |
US201213439829 |
申请日期 |
2012.04.04 |
申请人 |
GlaxoSmithKline Biologicals S.A. |
发明人 |
Boutriau Dominique;Capiau Carine;Desmons Pierre Michel;Lemoine Dominique;Poolman Jan |
分类号 |
A61K39/095;A61K39/116;A61K39/02;A61K47/48;A61K39/29;A61K39/102;A61K39/08;A61K39/05;C07H3/00;A61K39/385;A61K39/00 |
主分类号 |
A61K39/095 |
代理机构 |
|
代理人 |
Carter Barbara J. |
主权项 |
1. A multivalent immunogenic composition comprising the following components:
(a) killed whole-cell Bordetella pertussis, (b) tetanus toxoid, (c) diphtheria toxoid, (d) Hepatitis B surface antigen, (e) a conjugate of a carrier protein and the capsular polysaccharide of Haemophilus influenzae type B and (f) one or more conjugates of a carrier protein and the capsular polysaccharide of a bacterium selected from the group consisting of Neisseria meningitidis type A and N. meningitidis type C. |
地址 |
Rixensart BE |